The largest database of trusted experimental protocols

8 protocols using bond 3 automated system

1

Molecular Profiling of Lung Tumor Specimens

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor specimens were snap-frozen in liquid nitrogen within 20 min of surgical removal and stored at −80 °C until use. DNA was extracted by standard proteinase K digestion and phenol–chloroform extraction. For analysis of EGFR mutations, we examined four exons (exons 18–21) that encode the tyrosine kinase domain of the EGFR gene. For exons 18 (G719X), 20 (S768I and T790M), and 21 (L858R and L861Q), the TaqManTM SNP Genotyping Assay (Applied Biosystems, Foster City, CA, USA) was performed, according to the manufacturer’s instructions. Fragment analysis was conducted for the exon 19 deletion and the exon 20 insertion, as described previously [20 (link),21 (link)]. To analyze KRAS mutations, we directly sequenced codons 12, 13 and 61, as described previously [20 (link),21 (link)]. To detect ALK fusions, we performed ALK immunohistochemistry using an anti-ALK mouse monoclonal antibody (1:50; clone: 5A4, Leica Biosystems Newcastle Ltd., Newcastle, UK) and the Leica Bond III automated system (Leica Biosystems Melbourne Pty Ltd., Melbourne, Australia). The sections were incubated at pH 9 for 30 min at 100 °C. All fusions in the ALK-positive cases were confirmed by fluorescence in situ hybridization, as described previously [26 (link)].
+ Open protocol
+ Expand
2

EGFR, KRAS, and ALK Mutation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor specimens were snap-frozen in liquid nitrogen typically within 20 min after surgical resection and stored at −80°C until use. DNA was extracted using a standard proteinase K digestion and phenol-chloroform extraction. For analysis of the EGFR mutation, we examined four exons (exons 18–21) that code for the tyrosine kinase domain of the EGFR gene. For exons 18 (G719X), 20 (S768I and T790M), and 21 (L858R and L861Q), the TaqMan™ SNP Genotyping Assay kit (Applied Biosystems, Foster City, CA, USA) was used according to the manufacturer's instructions. For exon 19 deletion and exon 20 insertion, a fragment analysis was conducted, as previously described [43 (link)]. For the analysis of KRAS mutation, we performed direct sequencing assays for codons 12, 13, and 61, as previously described [43 (link)].
For detection of ALK fusion, we performed immunohistochemistry using an anti-ALK mouse monoclonal antibody (clone: 5A4, Leica Biosystems Newcastle Ltd., UK; diluted 1:50) and the Leica Bond III automated system (Leica Biosystems Melbourne Pty Ltd). The sections were incubated at pH 9 for 30 min at 100°C. In the ALK-positive tumors, ALK fusions were confirmed by fluorescence in situ hybridization, as previously described [27 (link)].
+ Open protocol
+ Expand
3

Quantifying BAP1 Expression in FFPE Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin fixed and paraffin-embedded (FFPE) tumor sections had been stained with monoclonal antibodies against BAP1 with a red chromogen (1:40, Santa Cruz Biotechnology, Dallas, Texas, USA). The Leica Bond-III automated system (Leica, Wetzlar, Germany) and digitally scanned to the .ndpi file format at × 400, using the Nano Zoomer 2.0 HT scan (Hamamatsu Photonics K.K., Hamamatsu, Japan). The QuPath Bioimage analysis software (v0.2.3) run on an Apple computer (Apple Inc., Cupertino, CA), had been used for digital image analysis39 (link). Each full tumor section was then analyzed for the number of tumor cells, number of cells with loss of BAP1 expression and retained expression, respectively, and size measurements for each individual cell (maximum and minimum caliper). Cell measurements were obtained from the 61 tumors in the first cohort and were validated in the second and third cohorts. A workflow for morphometric analysis was established using the QuPath software. The staining, scanning, digital image analysis, and cell measurement steps used for the included cohorts have been described previously10 (link),18 (link),19 (link),33 (link).
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of PALB2 in Chordoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chordoma tissues from the 187 chordoma patients were fixed with formalin and embedded in paraffin for following TMA construction. After assayed by TMA using the Tissue Array MiniCore (ALPHELYS, Plaisir), the most representative parts of the tissue were selected to build the TMA. Then TMAs were cut into 4μm thick sections for further staining with Leica RM 2135 Rotary Microtome (Rankin, Wetzlar, Germany). Leica BOND III automated system was used to perform Immunohistochemical staining with primary antibody (anti-PALB2 antibody, ab-202970, abcam, 1:500) and Bond Polymer Refine Detection (Leica Biosystems, DS9800) including secondary antibody. Leica Aperio AT2 scanner was used to scan TMA images at 400× magnification. Three pathologists examined the slides independently. Then, we analyzed the images by Leica Aperio ImageScope software (version 12.3). The H-score was used to evaluate staining intensity. H-Score (12 (link)) = 1 × (percent of light staining cells) + 2 × (percent of moderate staining cells) + 3 × (percent of strong staining cells).
+ Open protocol
+ Expand
5

Immunohistochemical Analysis of FAP, Cell Markers in Glioma and Xenograft Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
IHC staining was performed using a Leica BOND III automated system. Anti‐FAP antibody (ab207178, 1:400) was used for the IHC staining of tumor tissues from patients with glioma. Immunostained slides of TMA sections were scanned using a Leica Aperio AT2 scanner (at 400× magnification) and analyzed using a Leica Aperio ImageScope v12.3. The automated algorithm scored the staining of each tissue core as negative (0), weak (1+), moderate (2+), or strong (3+) according to the scoring criteria threshold. The algorithms also determined the percentage of positive staining. Then, the H‐score of each case was established using the formula H‐score = 1 × (percentage of 1+ cores) + 2 × (percentage of 2+ cores) + 3 × (percentage of 3+ cores). Thus, the H‐score ranged from 0 to 300.13 FAP (ab207178), Ki‐67 (ab15580), E‐cad (Cell Signaling Technology, #14472), and N‐cad (Cell Signaling Technology, #13116) antibodies were used for the IHC staining of subcutaneous tumors from BALB/c athymic nude mice.
+ Open protocol
+ Expand
6

Comprehensive Immunohistochemical Profiling of FFPE Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was conducted using 5 μm formalin-fixed paraffin-embedded (FFPE) whole tissue sections. Staining for common markers including Pax8 (Proteintech, 1:100), CK7 (OV-TL 12/30, DAKO, 1:800), CK20 (Ks20.8, DAKO, 1:1600), CD117 (Cat# A4502, DAKO, 1:1000), TFE3 (MRQ37, Cell Marque), HMB45 (HMB45, DAKO, 1:100), and Melan A (A103, Ventana) was performed using a BenchMark automated system (Roche). Staining for cathepsin-K (3F9, ABCAM, 1:5000) and FH (J13, Santa Cruz, 1:2500) was accomplished using a Bond III automated system (Leica). Staining for SDHB (21A11, Abcam, 1: 100), phospho-S6 (Ser235/236) (D57.2.2E, Cell Signaling Technology, 1:100), and phospho-4E-BP1 (Thr37/46) (236B4, Cell Signaling Technology, 1:400) was performed using an automated Ventana Discovery system (Roche). For CK7 and CK20 staining, the result was interpreted as “negative” if no or rare (<5%) cells staining positive. Immunostaining scores (H-scores) for phospho-S6 and phospho-4E-BP1 were determined as [H= intensity (0–3) x percentage of positive cells (1–100)].
+ Open protocol
+ Expand
7

Quantifying Tumor Progression via Bioluminescence

Check if the same lab product or an alternative is used in the 5 most similar protocols
SKOV3-ipLucshSC or SKOV3-ipLucshJLP cells (5 × 106 in 0.2 mL PBS) were intraperitoneally injected into the lower right quadrant of 1.5-month old female nu/nu nude mice (Charles River, Wilmington, MA). The progression of injected cells was monitored by in vivo bioluminescence on an IVIS Spectrum imaging system (PerkinElmer, Waltham, MA). Intraperitoneal injection of D-Luciferin (PerkinElmer) was administered to the isofluorane-anesthetized mice at 150 mg/kg of body weight. After 10 minutes, the mice were re-anesthetized and the bioluminescent images were taken at both ventral and dorsal positions. The radiance of the bioluminescence was quantified as photons per second. After euthanasia, the xenograft tumors were excised, fixed in 10% formalin, and used to create the tumor tissue microarray (TMA). TMA was constructed at the Cancer Tissue Pathology Core of the Stephenson Cancer Center. IHC staining was carried out as described above on a BOND-III automated system (Leica, Buffalo Grove, IL). Intensity of strong positive (Isp) per square micrometer of the IHC image was quantified using Spectrum software (Aperio, Vista, CA).
+ Open protocol
+ Expand
8

Immunohistochemical Analysis of Tissue Microarrays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two 2.0-mm diameter samples were removed then transferred to a recipient paraffin block to construct TMAs using a Tissue Array MiniCore 3 (ALPHELYS, Plaisir, France). Samples (4-µm thick) were obtained from each TMA with Leica Rotary Microtome RM2135 (Wetzlar, Germany). Immunohistochemical staining was performed on Leica BOND III automated system. All samples were pretreated in a 65 °C oven for 1.5 h. Staining was performed with dewaxing and epitope retrieval. Samples were blocked with peroxide solution for 7 min. Selected antibodies (shown in Additional file 1: Table S1) were used to incubate samples, followed by post-primary for 8 min, polymer for 8 min, diaminobenzidine (DAB) for 5 min, and hematoxylin counterstain for 2 min. Finally, the samples were dehydrated, cleared, then fixed with neutral resins. Stained samples were scanned with Leica Aperio AT2 scanner (400× magnification) and analysed by two different pathologists. Samples were scored as negative (0+), weak (1+), moderate (2+), and strong (3+) signal. The percentage of positivity was also calculated by two pathologists. The histological scores (H-Score) was calculated using following formula: H-Score = 0 × (percentage of negative) + 1 × (percentage of weak) + 2 × (percentage of moderate) + 3 × (percentage of strong). Thus, the H-Score ranges from 0 to 300 [5 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!